sdz nvi-085 has been researched along with idazoxan in 1 studies
| Studies (sdz nvi-085) | Trials (sdz nvi-085) | Recent Studies (post-2010) (sdz nvi-085) | Studies (idazoxan) | Trials (idazoxan) | Recent Studies (post-2010) (idazoxan) |
|---|---|---|---|---|---|
| 10 | 1 | 0 | 1,499 | 40 | 123 |
| Protein | Taxonomy | sdz nvi-085 (IC50) | idazoxan (IC50) |
|---|---|---|---|
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.0083 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0195 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.0195 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.0537 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0195 | |
| Alpha-1A adrenergic receptor | Homo sapiens (human) | 2.884 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0195 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clarke, DE; Ford, AP; Lachnit, WG | 1 |
1 other study(ies) available for sdz nvi-085 and idazoxan
| Article | Year |
|---|---|
SDZ NVI 085, an alpha 1A-adrenoceptor agonist with 5-HT2A receptor antagonist properties.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Bridged-Ring Compounds; Idazoxan; Ketanserin; Male; Muscle Contraction; Muscle, Smooth, Vascular; Oxazines; Prazosin; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Regional Blood Flow; Serotonin Antagonists; Tail | 1996 |